Although cholesterol-lowering guidance often touts the achievement of very low levels of low-density lipoprotein (LDL) cholesterol, emerging research demonstrates possible safety risks.
Maria DelPizzo, Senior Clinical Pharmacist
Advertisement
Articles by Maria DelPizzo, Senior Clinical Pharmacist
Advertisement
Latest Updated Articles
Reassessing the Safety and Efficacy of Very Low LDL CholesterolPublished: July 9th 2025 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Amivantamab for EGFR-Mutated Metastatic Non–Small Cell Lung Cancer
2
Breaking News: CVS Buys Rite Aid, Bartell Drugs
3
Operationalizing Epcoritamab-GemOx in Practice: A Focus on EPCORE NHL-2
4
Celebrating the Pharmacist’s Impact: How Pharmacists Elevate Care in Every Setting
5
